Phio Pharmaceuticals Corp reports results for the quarter ended in September - Earnings Summary

Phio Pharmaceuticals

11/11/2021 09:55

* Phio Pharmaceuticals Corp  PHIO.OQ  reported a quarterly
adjusted loss of 28 cents​​ per share for the quarter ended in
September. The lone analyst forecast for the quarter was for a
loss of 25 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Phio Pharmaceuticals Corp's reported EPS for the quarter was a
loss of 28 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Phio Pharmaceuticals Corp shares had fallen by 19.7% this
quarter and lost 39.4% so far this year.
* The company reported a quarterly loss of $3.74 million.
* Wall Street's median 12-month price target for Phio
Pharmaceuticals Corp is $6.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 11 at 09:55 a.m.
 ​All figures in US dollars unless otherwise stated